Our speakers reviewed and discussed the history of a technique called Facilitated Communication, purportedly used to communicate with individuals with severe autism,  developmental delay, or brain injuries. The technique has since been comprehensively debunked--watch and learn how providers can go wrong by failing to adhere to standards of evidence.

If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? 

Explore the pros and cons of managing genetic information via public and proprietary companies. 

Even in the US, some controversy persists over the conceptual defensibility of brain death. Around the world, the philosophical defensibility of brain death is even more debatable. 

James Corbett

Harvard Gazette
By John Laidler, Harvard Correspondent
Shifts in the field can allow providers both to prosper and serve patients better, speaker James Corbett says.

Register now for the Annual Bioethics Conference

This multidisciplinary program was co-sponsored by the Center for Bioethics at Harvard Medical School and 

ALS neuroethics lecture

Patients with ALS have a uniformly fatal disease, and one might worry that ALS patients are even more prone to the therapeutic misconception. In this video, panelists discuss evidence for therapeutic misconception in ALS trials.

Neurologists who treat epilepsy face substantial difficulty distinguishing "true" seizures caused by abnormal electrical discharges from seizures that are caused by psychological factors (psychogenic nonepileptic seizures, or PNES).

A Conversation with Charles Bosk, December 10th at Harvard Medical School